We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Synthetic Mammography Could Become the New Standard for 2D Breast Cancer Screening

By HospiMedica International staff writers
Posted on 02 Oct 2023

Full-field digital mammography (FFDM) is widely recognized as the go-to method for 2D screening of breast cancer because it's reliable, cost-effective, and broadly accessible. More...

However, the U.S. Food and Drug Administration (FDA) has also given the green light to alternative methods like synthetic mammography, especially when used alongside digital breast tomosynthesis (DBT). Synthetic mammography is a technique that reconstructs a 2D image using existing 3D DBT data. Nevertheless, there is still a debate over the accuracy of synthetic mammography, and information about the technique’s advantages and disadvantages remains limited.

Researchers from Brigham and Women's Hospital (Boston, MA, USA) have conducted an analysis that highlights reduced radiation exposure as the most significant benefit of synthetic mammography: While DBT offers a 3D view of the breast, a 2D image is needed to complete the imaging, which typically involves the use of FFDM and additional radiation. Synthetic mammography, however, can generate this 2D image artificially, thus minimizing radiation exposure. Despite this, the technique does have its downsides, including a lower spatial resolution, reduced visibility, and a higher rate of false-positive findings. There's also a possibility of encountering more image artifacts, although proper examination of the artifacts can help address this issue.

According to the researchers, despite these drawbacks, synthetic mammography is on track to become more prevalent than FFDM when combined with DBT. This is largely because the method's reduced radiation levels are particularly beneficial for breast cancer patients who are awaiting surgery. As the technique gains popularity and becomes more widely used, technological enhancements are following suit, including the potential use of artificial intelligence to refine the imaging process. Companies are focusing on developing new algorithms to produce clearer and more accurate synthetic mammography images. With ongoing investment and regulatory support, advancements in this technique are likely just a matter of time, and the benefits could eventually tip the scale in its favor.

Related Links:
Brigham and Women's Hospital 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.